MassMutual Private Wealth & Trust’s ANI Pharmaceuticals ANIP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11K	Hold	133	–	–	﹤0.01%	1365
2026 Q1	$10.2K	Hold	133	–	–	﹤0.01%	1360
2025 Q4	$10.5K	Sell	133 -1	-0.7%	-$87	﹤0.01%	1368
2025 Q3	$12.3K	Buy	134 +6	+5%	+$489	﹤0.01%	1308
2025 Q2	$8.35K	Buy	128 +45	+54%	+$2.93K	﹤0.01%	1430
2025 Q1	$5.56K	Buy	+83	New	+$4.96K	﹤0.01%	1554
2021 Q3	–	Sell	-48	Closed	-$2K	–	1258
2021 Q2	$2K	Buy	+48	New	+$1.63K	﹤0.01%	989
2018 Q3	–	Sell	-23	Closed	-$1.54K	–	975
2018 Q2	$1.54K	Hold	23	–	–	﹤0.01%	925
2018 Q1	$1.34K	Buy	+23	New	+$1.46K	﹤0.01%	897

Other funds holding ANIP

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MassMutual Private Wealth & Trust's ANIP Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 133 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1365.

MassMutual Private Wealth & Trust first reported a position in ANIP in Q1 2018 and has held it in 9 quarters since. The position peaked at $12.3K in Q3 2025. 63 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

MassMutual Private Wealth & Trust held 133 shares of ANI Pharmaceuticals worth $11K as of Q2 2026.
MassMutual Private Wealth & Trust left its ANI Pharmaceuticals share count unchanged in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1365 holding.
MassMutual Private Wealth & Trust first reported a position in ANI Pharmaceuticals in Q1 2018 and has held it in 9 quarters since.
MassMutual Private Wealth & Trust's ANI Pharmaceuticals position peaked at $12.3K in Q3 2025.
63 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.